Replies to post #107637 on Biotech Values

[10nisman]

MNTA

Very quickly, as I am headed to work, appears that the COG number is just below 40%.

I come up with a COGS number of around 32.7% in the quarter.

10nis

[Rocky3]

Very quickly, as I am headed to work, appears that the COG number is just below 40%.

I get 33%.

44 x 2 = 88 (normal MNTA share share if no reimbursement, assumes not fully paid)

88 / .45 = 195.55 (net income of product)

195.55 / 292 = 66.97% net income ratio

1 - .6697 = .3303 = 33.33% COGS

Corrections eveyone?

[iwfal]

MNTA -

appears that the COG number is just below 40%.

Agreed that that is the COGS number - but assumes several things:

a) The portion of back expenses owed by MNTA is same as profit share.

b) That there weren't one-time distortions added by start up (e.g. if starting inventory was done on R&D then the COGS will look better than they really are)

--------------------------

Also note that I am on record as expecting low range of COGS due to need to reverse engineer manufacturing process to match end product. I.e. 40% sounds reasonable to me. But we really need to wait a quarter before really knowning.